These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 31770603)

  • 21. Assessment of minocycline and polymyxin B combination against Acinetobacter baumannii.
    Bowers DR; Cao H; Zhou J; Ledesma KR; Sun D; Lomovskaya O; Tam VH
    Antimicrob Agents Chemother; 2015 May; 59(5):2720-5. PubMed ID: 25712362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biofilm prevention concentrations (BPC) of minocycline compared to polymyxin B, meropenem, and amikacin against Acinetobacter baumannii.
    Beganovic M; Luther MK; Daffinee KE; LaPlante KL
    Diagn Microbiol Infect Dis; 2019 Jul; 94(3):223-226. PubMed ID: 30827805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In Vivo and In Vitro Efficacy of Minocycline-Based Combination Therapy for Minocycline-Resistant Acinetobacter baumannii.
    Yang YS; Lee Y; Tseng KC; Huang WC; Chuang MF; Kuo SC; Lauderdale TL; Chen TL
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4047-54. PubMed ID: 27114274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is minocycline a solution for multidrug-resistant Acinetobacter baumannii?
    Neonakis IK; Spandidos DA; Petinaki E
    Future Microbiol; 2014; 9(3):299-305. PubMed ID: 24762305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative evaluation of minocycline susceptibility testing methods in carbapenem-resistant Acinetobacter baumannii.
    Dimitriadis P; Protonotariou E; Varlamis S; Poulou A; Vasilaki O; Metallidis S; Tsakris A; Malisiovas N; Skoura L; Pournaras S
    Int J Antimicrob Agents; 2016 Sep; 48(3):321-3. PubMed ID: 27451087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of TP-6076 against carbapenem-resistant Acinetobacter baumannii isolates collected from inpatients in Greek hospitals.
    Falagas ME; Skalidis T; Vardakas KZ; Voulgaris GL; Papanikolaou G; Legakis N;
    Int J Antimicrob Agents; 2018 Aug; 52(2):269-271. PubMed ID: 29559273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the Accelerate Pheno System for Identification of
    Bowler SL; Towne JW; Humphries RM; Doi Y
    J Clin Microbiol; 2019 Mar; 57(3):. PubMed ID: 30651391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Minocycline activity tested against Acinetobacter baumannii complex, Stenotrophomonas maltophilia, and Burkholderia cepacia species complex isolates from a global surveillance program (2013).
    Flamm RK; Castanheira M; Streit JM; Jones RN
    Diagn Microbiol Infect Dis; 2016 Jul; 85(3):352-355. PubMed ID: 27112832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
    Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
    Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative assessment of combination antimicrobial therapy against multidrug-resistant Acinetobacter baumannii.
    Lim TP; Ledesma KR; Chang KT; Hou JG; Kwa AL; Nikolaou M; Quinn JP; Prince RA; Tam VH
    Antimicrob Agents Chemother; 2008 Aug; 52(8):2898-904. PubMed ID: 18505848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro pharmacodynamics of human-simulated exposures of ampicillin/sulbactam, doripenem and tigecycline alone and in combination against multidrug-resistant Acinetobacter baumannii.
    Housman ST; Hagihara M; Nicolau DP; Kuti JL
    J Antimicrob Chemother; 2013 Oct; 68(10):2296-304. PubMed ID: 23710070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Target site antimicrobial activity of colistin might be misestimated if tested in conventional growth media.
    Matzneller P; Strommer S; Österreicher Z; Mitteregger D; Zeitlinger M
    Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):1989-94. PubMed ID: 26178070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Minocycline: an old drug for a new bug: multidrug-resistant Acinetobacter baumannii.
    Goff DA; Kaye KS
    Clin Infect Dis; 2014 Dec; 59 Suppl 6():S365-6. PubMed ID: 25371511
    [No Abstract]   [Full Text] [Related]  

  • 34. Identification and bioevaluation of SRI-12742 as an antimicrobial agent against multidrug-resistant Acinetobacter baumannii.
    Shukla M; Soni I; Matsuyama K; Tran T; Tanga M; Gong L; Chopra S
    Int J Antimicrob Agents; 2018 Jul; 52(1):22-27. PubMed ID: 29501820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activity of minocycline alone and in combination with cefoperazone-sulbactam against carbapenem-resistant Acinetobacter baumannii.
    Pei G; Mao Y; Sun Y
    Microb Drug Resist; 2012 Dec; 18(6):574-7. PubMed ID: 22928863
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Rodríguez CH; Nastro M; Vay C; Famiglietti A
    Microb Drug Resist; 2021 Nov; 27(11):1560-1563. PubMed ID: 33926231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Minocycline activity against clinical isolates of multidrug-resistant Acinetobacter baumannii.
    Adibhesami H; Douraghi M; Rahbar M; Abdollahi A
    Clin Microbiol Infect; 2015 Nov; 21(11):e79-80. PubMed ID: 26197214
    [No Abstract]   [Full Text] [Related]  

  • 38. Minocycline--an old drug for a new century: emphasis on methicillin-resistant Staphylococcus aureus (MRSA) and Acinetobacter baumannii.
    Bishburg E; Bishburg K
    Int J Antimicrob Agents; 2009 Nov; 34(5):395-401. PubMed ID: 19665876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of medium type, age and aeration on the MICs of tigecycline and classical tetracyclines.
    Hope R; Warner M; Mushtaq S; Ward ME; Parsons T; Livermore DM
    J Antimicrob Chemother; 2005 Dec; 56(6):1042-6. PubMed ID: 16286361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prevalence of the tetA and tetB genes as mechanisms of resistance to tetracycline and minocycline in Acinetobacter baumannii clinical isolates].
    Martí S; Fernández-Cuenca F; Pascual A; Ribera A; Rodríguez-Baño J; Bou G; Miguel Cisneros J; Pachón J; Martínez-Martínez L; Vila J;
    Enferm Infecc Microbiol Clin; 2006 Feb; 24(2):77-80. PubMed ID: 16545313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.